Grant: CIHR Fellowship
University of Toronto
$90,000.00
Electric field stimulated regeneration of post-stroke ischemic lesion using injectable cell-laden biohybrid hydrogel system
FY 2015-16
Summary
In spite of the remarkable advances in pharmacological, interventional, and surgical therapies to date, ischemic brain stroke remains one of the leading causes of mortality and lifelong impairments in humans. Since the degree of endogenous neurogenesis and functional recovery are often constrained in response to stroke, stem cell transplantation is a promising approach to restore functional neuronal circuits. However, therapeutic outcomes are often limited by poor survival of transplanted cells, uncontrolled cell differentiation, and/or ineffective engraftment with host tissues. To overcome these limitations and enable the potential of stem cell therapy to be realized, I propose to formulate a stem cell-laden injectable biocomposite hydrogel system that incorporates neuroprotectants, along with the simultaneous application of an electric field (EF) in order to establish a localized electrical environment at the ischemic zone. The use of stem cell-laden hydrogel-based electroactive composites are intended to both promote therapeutic neural tissue regeneration at the ischemic microenvironment and accelerate regeneration of damaged neuronal tissue. Given the importance of electrical stimulation on brain function, the application of external EF will facilitate self-repair of the brain by stimulating endogenous neurogenesis and enhancing cerebral blood flow. This will in turn promote greater survival and integration of transplanted cells. Thus, the precise presentation of a combinatorial hybrid platform encompassing cells and neuroprotectants, concurrent with EF can serve as a potential therapeutic strategy for the treatment of stroke. Designing such a permissive injectable micro-environment that can crosslink in situ to form three dimensional hydrogel structures will eventually be beneficial in improving the quality of life of an increasing number of stroke survivors.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
339415
Name
Thrivikraman Greeshma
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Electric field stimulated regeneration of post-stroke ischemic lesion using injectable cell-laden biohybrid hydrogel system
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$90,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Tissue Engineering
Abstract
In spite of the remarkable advances in pharmacological, interventional, and surgical therapies to date, ischemic brain stroke remains one of the leading causes of mortality and lifelong impairments in humans. Since the degree of endogenous neurogenesis and functional recovery are often constrained in response to stroke, stem cell transplantation is a promising approach to restore functional neuronal circuits. However, therapeutic outcomes are often limited by poor survival of transplanted cells, uncontrolled cell differentiation, and/or ineffective engraftment with host tissues. To overcome these limitations and enable the potential of stem cell therapy to be realized, I propose to formulate a stem cell-laden injectable biocomposite hydrogel system that incorporates neuroprotectants, along with the simultaneous application of an electric field (EF) in order to establish a localized electrical environment at the ischemic zone. The use of stem cell-laden hydrogel-based electroactive composites are intended to both promote therapeutic neural tissue regeneration at the ischemic microenvironment and accelerate regeneration of damaged neuronal tissue. Given the importance of electrical stimulation on brain function, the application of external EF will facilitate self-repair of the brain by stimulating endogenous neurogenesis and enhancing cerebral blood flow. This will in turn promote greater survival and integration of transplanted cells. Thus, the precise presentation of a combinatorial hybrid platform encompassing cells and neuroprotectants, concurrent with EF can serve as a potential therapeutic strategy for the treatment of stroke. Designing such a permissive injectable micro-environment that can crosslink in situ to form three dimensional hydrogel structures will eventually be beneficial in improving the quality of life of an increasing number of stroke survivors.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Thrivikraman, Greeshma
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $90,000~ $0~